SHAW CHRISTINE (VP, Assay Development) reported 1 transaction at GENMARK DIAGNOSTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/22/2021ACC: 0001487371-21-000176
Officer· VP, Assay Development
Since Aug 2020
-118.82K
Net shares
Net seller
$2.44M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
118.82K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−101.32K
Price / share
$24.05
Trade value
$2.44M
% of position
New position
4/22/2021
101.32K→0.00
Total
Net shares
−101.32K
Net value
-$2.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2021 | U · U | −101.32K | $24.05 | $2.44M | New position | 101.32K | 0.00 |
| Total | −101.32K | -$2.44M | ||||||
Derivative Transactions1
Market Stock Units
Direct
Converts to
Common Stock
17.50K shares
Shares
−17.50K
Strike price
0.0
Held after
0.00
Exercisable
—
4/22/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Market Stock Units Direct | Common Stock17.50K shares | 4/22/2021 | D · Disposition | −17.50K | 0.0 | — | 0.00 |